AAAAAA

   
Results: 1-23 |
Results: 23
Spongistatins as tubulin targeting agents
Authors: Uckun, FM Mao, C Jan, ST Huang, H Vassilev, AO Navara, CS Narla, RK
Citation: Fm. Uckun et al., Spongistatins as tubulin targeting agents, CUR PHARM D, 7(13), 2001, pp. 1291-1296
In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me-2-Phen)(2)]}
Authors: Narla, RK Chen, CL Dong, YH Uckun, FM
Citation: Rk. Narla et al., In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me-2-Phen)(2)]}, CLIN CANC R, 7(7), 2001, pp. 2124-2133
Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity
Authors: Narla, RK Dong, YH Klis, D Uckun, FM
Citation: Rk. Narla et al., Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity, CLIN CANC R, 7(4), 2001, pp. 1094-1101
Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells
Authors: Narla, RK Navara, C Sarquis, M Uckun, FM
Citation: Rk. Narla et al., Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells, LEUK LYMPH, 41(5-6), 2001, pp. 615
Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me-2-Phen)(2)] depolarizes mitochondrial membranes
Authors: Narla, RK Dong, YH Uckun, FM
Citation: Rk. Narla et al., Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me-2-Phen)(2)] depolarizes mitochondrial membranes, LEUK LYMPH, 41(5-6), 2001, pp. 625
Vanadocenes as potent anti-proliferative agents disrupting mitotic spindleformation in cancer cells
Authors: Navara, CS Benyumov, A Vassilev, A Narla, RK Ghosh, P Uckun, FM
Citation: Cs. Navara et al., Vanadocenes as potent anti-proliferative agents disrupting mitotic spindleformation in cancer cells, ANTI-CANC D, 12(4), 2001, pp. 369-376
X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex, [VCp2(acac)](CF3SO3): a dual-function anti-cancer agent with anti-angiogenic and anti-mitotic properties
Authors: Ghosh, P Ghosh, S Navara, C Narla, RK Benyumov, A Uckun, FM
Citation: P. Ghosh et al., X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex, [VCp2(acac)](CF3SO3): a dual-function anti-cancer agent with anti-angiogenic and anti-mitotic properties, J INORG BIO, 84(3-4), 2001, pp. 241-253
Apoptosis-inducing vanadocene compounds against human testicular cancer
Authors: Ghosh, P D'Cruz, OJ Narla, RK Uckun, FM
Citation: P. Ghosh et al., Apoptosis-inducing vanadocene compounds against human testicular cancer, CLIN CANC R, 6(4), 2000, pp. 1536-1545
Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent
Authors: Narla, RK Dong, YH D'Cruz, OJ Navara, C Uckun, FM
Citation: Rk. Narla et al., Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent, CLIN CANC R, 6(4), 2000, pp. 1546-1556
Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity
Authors: Perrey, DA Narla, RK Uckun, FM
Citation: Da. Perrey et al., Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity, BIOORG MED, 10(6), 2000, pp. 547-549
The S-alkyl chain length as a determinant of the anti-leukemic activity ofcysteine chloromethyl ketone compounds
Authors: Perrey, DA Scannell, MP Narla, RK Uckun, FM
Citation: Da. Perrey et al., The S-alkyl chain length as a determinant of the anti-leukemic activity ofcysteine chloromethyl ketone compounds, BIOORG MED, 10(6), 2000, pp. 551-552
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity
Authors: Dong, YH Venkatachalam, TK Narla, RK Trieu, VN Sudbeck, EA Uckun, FM
Citation: Yh. Dong et al., Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity, BIOORG MED, 10(1), 2000, pp. 87-90
Apoptosis-inducing vanadium complexes
Authors: Narla, RK Dong, YH Ghosh, P Thoen, K Uckun, FM
Citation: Rk. Narla et al., Apoptosis-inducing vanadium complexes, DRUG FUTURE, 25(10), 2000, pp. 1053-1068
Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice
Authors: Getchell, TV Narla, RK Little, S Hyde, JF Getchell, ML
Citation: Tv. Getchell et al., Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice, CELL TIS RE, 299(2), 2000, pp. 185-192
Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes
Authors: Dong, YH Narla, RK Sudbeck, E Uckun, FM
Citation: Yh. Dong et al., Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes, J INORG BIO, 78(4), 2000, pp. 321-330
EGF-Genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model
Authors: Trieu, VN Narla, RK Myers, DE Uckun, FM
Citation: Vn. Trieu et al., EGF-Genistein inhibits neointimal hyperplasia after vascular injury in an experimental restenosis model, J CARDIO PH, 35(4), 2000, pp. 595-605
A quantitative HPLC detection method for WHI-P154 [4-(3 '-bromo-4 '-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline]
Authors: Chen, CL Narla, RK Liu, XP Uckun, FM
Citation: Cl. Chen et al., A quantitative HPLC detection method for WHI-P154 [4-(3 '-bromo-4 '-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline], J LIQ CHR R, 22(11), 1999, pp. 1771-1783
Structure-based design of specific inhibitors of janus kinase 3 as apoptosis-inducing antileukemic agents
Authors: Sudbeck, EA Liu, XP Narla, RK Mahajan, S Ghosh, S Mao, C Uckun, FM
Citation: Ea. Sudbeck et al., Structure-based design of specific inhibitors of janus kinase 3 as apoptosis-inducing antileukemic agents, CLIN CANC R, 5(6), 1999, pp. 1569-1582
A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cells
Authors: Zhu, DM Fang, WH Narla, RK Uckun, FM
Citation: Dm. Zhu et al., A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cells, CLIN CANC R, 5(2), 1999, pp. 355-360
Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents
Authors: Ghosh, S Narla, RK Zheng, YG Liu, XP Jun, X Mao, C Sudbeck, EA Uckun, FM
Citation: S. Ghosh et al., Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents, ANTI-CAN DR, 14(5), 1999, pp. 403-410
Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes
Authors: Aubrecht, J Narla, RK Ghosh, P Stanek, J Uckun, FM
Citation: J. Aubrecht et al., Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes, TOX APPL PH, 154(3), 1999, pp. 228-235
Increased hydroxyl radical production and apoptosis in PC12 neuron cells expressing the gain-of-function mutant G93A SOD1 gene
Authors: Liu, RG Narla, RK Kurinov, I Li, BL Uckun, FM
Citation: Rg. Liu et al., Increased hydroxyl radical production and apoptosis in PC12 neuron cells expressing the gain-of-function mutant G93A SOD1 gene, RADIAT RES, 151(2), 1999, pp. 133-141
Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells
Authors: Zhu, DM Narla, RK Fang, WH Chia, NC Uckun, FM
Citation: Dm. Zhu et al., Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells, CLIN CANC R, 4(12), 1998, pp. 2967-2976
Risultati: 1-23 |